🇺🇸 FDA

Company profile · Sponsor

INTEGRATED

INTEGRATED BIOPHARMA INC

INBP · NYSE biotech HILLSIDE, NJ, USA
Pipeline
24
Drugs
0
Patents
8

Quick answer

INTEGRATED (INBP) is a biotech company. headquartered in HILLSIDE, NJ, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker INBP
Exchange NYSE
Company type biotech
Headquarters HILLSIDE, NJ, USA
SEC CIK 0001016504

Pipeline (24)

Search pipeline →

  1. BaidI Quzhi granule

    INTEGRATED

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  2. Donepezil

    INTEGRATED

    Osteoarthritis

    phase 3 small molecule active

    1 trial

  3. Ear pills

    INTEGRATED

    Intradialytic Hypotension

    phase 3 small molecule active

    1 trial

  4. G-Pen

    INTEGRATED

    Insulin Hypoglycemia

    phase 3 small molecule completed

    1 trial

  5. Galantamine

    INTEGRATED

    Acute Ischemic Stroke AIS

    phase 3 small molecule active

    1 trial

  6. Ginkgo Diterpene Lactone Meglumine Injection

    INTEGRATED

    Ischemic Stroke

    phase 3 small molecule active

    1 trial

  7. Ginkgo diterpene lactone meglumine injection

    INTEGRATED

    Ischemic Stroke, Acute

    phase 3 small molecule active

    1 trial

  8. Infliximab + methotrexate (IFX + MTX)

    INTEGRATED

    Arthritis, Psoriatic

    phase 3 small molecule completed

    1 trial

  9. Infliximab Increased Frequency

    INTEGRATED

    Rheumatoid Arthritis

    phase 3 small molecule terminated

    1 trial

  10. Intensive medical therapy

    INTEGRATED

    Myocardial Ischemia

    phase 3 other completed

    1 trial

  11. Juanbi pill

    INTEGRATED

    Juanbi Pill

    phase 3 small molecule active

    1 trial

  12. NiuBangZi pill or NiuBangZi pill placebo

    INTEGRATED

    Niu Bang Zi Pill

    phase 3 small molecule active

    1 trial

  13. PEG-Interferon a-2b + Ribavirin

    INTEGRATED

    Chronic Hepatitis C Infection in HIV-Infected Persons

    phase 3 small molecule completed

    1 trial

  14. Peg interferon alpha-2b

    INTEGRATED

    Hepatitis C

    phase 3 small molecule terminated

    1 trial

  15. PegIntron (peginterferon alfa-2b)

    INTEGRATED

    Hepatitis C, Chronic

    phase 3 mab terminated

    1 trial

  16. Picosulfate sodium, magnesium oxide, citric acid

    INTEGRATED

    Bowel Preparation Before Colonoscopy

    phase 3 small molecule completed

    1 trial

  17. Qing'E pills

    INTEGRATED

    Menopause

    phase 3 small molecule completed

    1 trial

  18. Quiklean® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP)

    INTEGRATED

    Bowel Preparation

    phase 3 small molecule completed

    1 trial

  19. Sevoflurane

    INTEGRATED

    Anesthesia

    phase 3 small molecule completed

    1 trial

  20. Surgery and HIPEC with Lobaplatin

    INTEGRATED

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  21. Tirofiban

    INTEGRATED

    Acute Ischemic Stroke

    phase 3 small molecule completed

    1 trial

  22. peginterferon alfa-2b (SCH 54031)

    INTEGRATED

    Hepatitis C, Chronic

    phase 3 mab completed

    1 trial

  23. 0.9% NaCl 2000ml

    INTEGRATED

    Brain Infarct

    phase 2 small molecule completed

    1 trial

  24. Autologous CD5 CAR T-cells

    INTEGRATED

    T-Cell Acute Lymphocytic Leukemia

    phase 2 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 12076377

    Variant sulfatase enzymes with enhanced properties

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11421021

    Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11260120

    Immunogenic composition comprising a fusion peptide derived from superantigen toxoids

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11186626

    Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11154614

    Method for producing virus like particles

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11135280

    Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11028153

    Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10653800

    Oligonucleotide-based probes for detection of bacterial nucleases

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is INTEGRATED?

INTEGRATED (INBP) is a biotech company. headquartered in HILLSIDE, NJ, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does INTEGRATED sponsor?

We track 24 ClinicalTrials.gov-linked programs for INTEGRATED, including BaidI Quzhi granule and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does INTEGRATED company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.